Judo Bio
Cambridge
About Judo Bio
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases. By leveraging its innovative receptor targeting approach, Judo Bio is developing a pipeline aimed at benefiting patients with both common and rare diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $100.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: judo.bio
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/judo-bio-81705 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.